These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23564776)

  • 61. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
    Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
    BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics.
    She JJ; Zhang PG; Wang X; Che XM; Wang ZM
    World J Gastroenterol; 2012 Sep; 18(33):4610-7. PubMed ID: 22969237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel approach for enriching cancer stem cells from the human SW-13 adrenocortical carcinoma cell line.
    Zeng W; Chen X; Ma Y; Huang Z; Qin Y; Wu F; Wu L; Liang X; Qin Y; Zhou J; Lu D; Kuang X; Li QQ; Luo Z
    Anticancer Res; 2014 Jan; 34(1):117-23. PubMed ID: 24403451
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors.
    Ikegame A; Ozaki S; Tsuji D; Harada T; Fujii S; Nakamura S; Miki H; Nakano A; Kagawa K; Takeuchi K; Abe M; Watanabe K; Hiasa M; Kimura N; Kikuchi Y; Sakamoto A; Habu K; Endo M; Itoh K; Yamada-Okabe H; Matsumoto T
    Leukemia; 2012 Sep; 26(9):2124-34. PubMed ID: 22430632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
    Signore M; Buccarelli M; Pilozzi E; De Luca G; Cappellari M; Fanciulli M; Goeman F; Melucci E; Biffoni M; Ricci-Vitiani L
    Oncotarget; 2016 Jul; 7(28):44113-44128. PubMed ID: 27286453
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro and ex vivo anti‑tumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2‑overexpressing leukemia cells.
    Jing W; Zhou M; Chen R; Ye X; Li W; Su X; Luo J; Wang Z; Peng S
    Oncol Rep; 2021 Mar; 45(3):1142-1152. PubMed ID: 33650639
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y; Oka M; Soda H; Shiozawa K; Yoshikawa M; Itoh A; Ikegami Y; Tsurutani J; Nakatomi K; Kitazaki T; Doi S; Yoshida H; Kohno S
    Cancer Res; 2005 Feb; 65(4):1541-6. PubMed ID: 15735043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
    Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
    Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling.
    Nakanishi T; Chumsri S; Khakpour N; Brodie AH; Leyland-Jones B; Hamburger AW; Ross DD; Burger AM
    Br J Cancer; 2010 Mar; 102(5):815-26. PubMed ID: 20145614
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical implications of cancer stem cell-like side population cells in human laryngeal cancer.
    Yu D; Jin C; Liu Y; Yang J; Zhao Y; Wang H; Zhao X; Cheng J; Liu X; Liu C
    Tumour Biol; 2013 Dec; 34(6):3603-10. PubMed ID: 23807678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of cancer stem-like cells derived from a side population of a human gallbladder carcinoma cell line, SGC-996.
    Li XX; Wang J; Wang HL; Wang W; Yin XB; Li QW; Chen YY; Yi J
    Biochem Biophys Res Commun; 2012 Mar; 419(4):728-34. PubMed ID: 22387537
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.
    Perego P; De Cesare M; De Isabella P; Carenini N; Beggiolin G; Pezzoni G; Palumbo M; Tartaglia L; Pratesi G; Pisano C; Carminati P; Scheffer GL; Zunino F
    Cancer Res; 2001 Aug; 61(16):6034-7. PubMed ID: 11507048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
    Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
    [TBL] [Abstract][Full Text] [Related]  

  • 76. C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.
    Bram EE; Ifergan I; Grimberg M; Lemke K; Skladanowski A; Assaraf YG
    Biochem Pharmacol; 2007 Jun; 74(1):41-53. PubMed ID: 17481587
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.
    Takahata T; Ookawa K; Suto K; Tanaka M; Yano H; Nakashima O; Kojiro M; Tamura Y; Tateishi T; Sakata Y; Fukuda S
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):399-407. PubMed ID: 18248513
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells.
    Takigawa N; Takeyama M; Kozuki T; Shibayama T; Hisamoto A; Kiura K; Tada A; Hotta K; Umemura S; Ohashi K; Fujiwara Y; Takata S; Ichihara E; Osawa M; Tabata M; Tanimoto M; Takahashi K
    Oncol Rep; 2007 May; 17(5):983-7. PubMed ID: 17390033
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells.
    Li H; Gao Q; Guo L; Lu SH
    Cancer Biol Ther; 2011 Jun; 11(11):950-8. PubMed ID: 21467840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.